REMEDIATION OF EMPHYSEMA--MECHANISMS, CHARACTERISTICS
肺气肿的治疗——机制、特点
基本信息
- 批准号:2600755
- 负责人:
- 金额:$ 33.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 2002-08-31
- 项目状态:已结题
- 来源:
- 关键词:RNase protection assay all trans retinol cell growth regulation computer assisted sequence analysis elastases electron microscopy electroporation emphysema gene expression gene targeting laboratory mouse laboratory rat lung alveolus molecular biology molecular cloning northern blottings nucleic acid sequence polymerase chain reaction protease inhibitor regeneration respiratory disorder chemotherapy respiratory pharmacology southern blotting statistics /biometry tissue /cell preparation vitamin therapy
项目摘要
DESCRIPTION: This applicant has had a long-standing interest in the
biology of the formation of pulmonary alveoli during post-natal
development. Recently, he has demonstrated that retinoic acid (RA) not
only promotes the post-natal development of alveoli in the rat but also
provides remediation of the tissue changes in an experimental model of
emphysema in adult rats. To investigate this finding further, his specific
aims are: 1) to use differential display (DD) and differential screening,
as components of a systematic search for genes that in rat lung have
unique and essential functions in the formation of alveoli during RA-
abrogation of elastase-induced emphysema. Selected analogous genes will be
cloned and "knocked-out" in mice and morphometric procedures use to
determine if there is an alteration of any of the following: a) septation
of the gas-exchange region in the newborn mouse; b) the post-septational
increase in alveolar number, or c) abrogation of elastase-induced
emphysema. 2) To use morphometric procedures to test the hypothesis a)
that in rats with elastase-induced emphysema the long's diffusion capacity
is diminished but increased after treatment with RA; b) that the RA-
induced abrogation of elastase produced emphysema persists after treatment
with RA is stopped; and c) that treatment of Tsk mice (which have
emphysema due to low serum and lung anti-elastase activity) with RA alone,
and with a protease inhibitor, will abrogate the emphysema. We believe our
preliminary data and the well documented areas of competence of those
involved in this proposal demonstrate the feasibility and likely success
of our pursuit of a new paradigm--the pharmacological remediation of
emphysema fostered by understanding the molecular basis of alveolus
formation.
描述:此申请者长期以来一直对
出生后肺泡形成的生物学研究
发展。最近,他证明了维甲酸(RA)不是
不仅促进大鼠肺泡的出生后发育,而且还
在实验模型中提供对组织变化的补救
成年大鼠的肺气肿。为了进一步调查这一发现,他的具体
目的是:1)使用差异显示(DD)和差异筛选,
作为系统寻找基因的组成部分,在大鼠肺中有
类风湿性关节炎时肺泡形成过程中独特而重要的功能
消除弹性酶诱导的肺气肿。选定的相似基因将是
小鼠的克隆和“敲除”和形态计量学程序用于
确定是否有以下任何变化:a)隔膜
新生小鼠的气体交换区;b)隔膜后
肺泡数增加,或c)弹性蛋白酶诱导的肺泡数减少
肺气肿。2)使用形态计量学程序检验假设a)
弹性酶诱导的肺气肿大鼠Long‘s扩散能力的研究
在RA治疗后减少但增加;b)RA-
弹性蛋白酶引起的肺气肿在治疗后持续被诱导消除
停止使用RA;以及c)治疗TSK小鼠(它们有
由于血清和肺抗弹力酶活性低而导致的肺气肿)单独患有RA,
用一种蛋白水解酶抑制剂,可以消除肺气肿。我们相信我们的
初步数据和有充分记录的这些人的能力领域
参与这项提议证明了其可行性和可能取得的成功
我们追求一种新的范式--药物治疗
通过了解肺泡的分子基础而形成肺气肿
队形。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DONALD John MASSARO其他文献
DONALD John MASSARO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DONALD John MASSARO', 18)}}的其他基金
Alveolar Biology: Sex, Age, and Alveolar Turnover
肺泡生物学:性别、年龄和肺泡周转率
- 批准号:
7250272 - 财政年份:2004
- 资助金额:
$ 33.96万 - 项目类别:
Alveolar Biology: Sex, Age, and Alveolar Turnover
肺泡生物学:性别、年龄和肺泡周转率
- 批准号:
7089868 - 财政年份:2004
- 资助金额:
$ 33.96万 - 项目类别:
Alveolar Biology: Sex, Age, and Alveolar Turnover
肺泡生物学:性别、年龄和肺泡周转率
- 批准号:
6827920 - 财政年份:2004
- 资助金额:
$ 33.96万 - 项目类别:
Alveolar Biology: Sex, Age, and Alveolar Turnover
肺泡生物学:性别、年龄和肺泡周转率
- 批准号:
6920656 - 财政年份:2004
- 资助金额:
$ 33.96万 - 项目类别:
ALVEOLUS FORMATION--MORPHOMETRIC AND MOLECULAR STUDIES
肺泡形成——形态学和分子研究
- 批准号:
6182871 - 财政年份:1999
- 资助金额:
$ 33.96万 - 项目类别:
ALVEOLUS FORMATION--MORPHOMETRIC AND MOLECULAR STUDIES
肺泡形成——形态学和分子研究
- 批准号:
6388824 - 财政年份:1999
- 资助金额:
$ 33.96万 - 项目类别:
ALVEOLUS FORMATION--MORPHOMETRIC AND MOLECULAR STUDIES
肺泡形成——形态学和分子研究
- 批准号:
6536768 - 财政年份:1999
- 资助金额:
$ 33.96万 - 项目类别:
ALVEOLUS FORMATION--MORPHOMETRIC AND MOLECULAR STUDIES
肺泡形成——形态学和分子研究
- 批准号:
6491229 - 财政年份:1999
- 资助金额:
$ 33.96万 - 项目类别:
ALVEOLUS FORMATION--MORPHOMETRIC AND MOLECULAR STUDIES
肺泡形成——形态学和分子研究
- 批准号:
6638199 - 财政年份:1999
- 资助金额:
$ 33.96万 - 项目类别:
ALVEOLUS FORMATION--MORPHOMETRIC AND MOLECULAR STUDIES
肺泡形成——形态学和分子研究
- 批准号:
2859334 - 财政年份:1999
- 资助金额:
$ 33.96万 - 项目类别:
相似海外基金
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A NEW ALL-TRANS-RETINOL METABOLITES
一种新的全反式视黄醇代谢物的合成和生物活性
- 批准号:
8361148 - 财政年份:2011
- 资助金额:
$ 33.96万 - 项目类别:
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A NEW ALL-TRANS-RETINOL METABOLITES
一种新的全反式视黄醇代谢物的合成和生物活性
- 批准号:
8168931 - 财政年份:2010
- 资助金额:
$ 33.96万 - 项目类别:
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A NEW ALL-TRANS-RETINOL METABOLITES
一种新的全反式视黄醇代谢物的合成和生物活性
- 批准号:
7954594 - 财政年份:2009
- 资助金额:
$ 33.96万 - 项目类别: